Comprehensive molecular profiling with whole-exome sequencing (WES) of PDX tumors

To identify biomarkers for the antitumor effects of molecularly targeted therapy, we performed whole-exome sequencing on 795 patient-derived xenograft (PDX) samples established from 269 patients with solid tumors and 125 frozen tissue samples obtained at the time of surgery.

• Type: Exome Sequencing
• Archiver: Japanese Genotype-phenotype Archive (JGA)